Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 6/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.60 |
| ▸ | NQO2 | P16083 | 4/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.57 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18898091 | 0.93 | SIGMAR1 (0.64) | MTNR1ASIGMAR1MTNR1BNQO2ABCB1 | |
| SCHEMBL8572116 | 0.93 | SIGMAR1 (0.64) | MTNR1ASIGMAR1MTNR1BNQO2ABCB1 | |
| SCHEMBL7953822 | 0.93 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL7951891 | 0.93 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL7950373 | 0.93 | MTNR1A (0.62) | MTNR1AMTNR1BNQO2 | |
| Hydrochloric Acid SCHEMBL7952286 | 0.91 | MTNR1A (0.61) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL3714924 | 0.90 | HTR6 (0.57) | MTNR1ASIGMAR1MTNR1BNQO2ABCB1 | |
| SCHEMBL10175562 | 0.88 | SIGMAR1 (0.61) | SIGMAR1ABCB1 | |
| SCHEMBL23788244 | 0.85 | MTNR1A (0.57) | MTNR1ASIGMAR1MTNR1BNQO2ABCB1 | |
| SCHEMBL14290815 | 0.85 | SIGMAR1 (0.64) | MTNR1ASIGMAR1MTNR1BNQO2ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016046833-A2 | IMPROVED PROCESSES FOR THE PREPARATION OF AGOMELATINE USING NOVEL INTERMEDIATES | SYMED LABS LIMITED (IN) | 2016-03-31 | — | — | WO | disclosed |
| EP-2580183-B1 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE | GADOR SA (AR) | 2014-07-23 | — | — | EP | disclosed |
| EP-2580183-B1 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE | GADOR SA (AR) | 2014-07-23 | — | — | EP | disclosed |
| WO-2014064706-A1 | PROCESSES FOR THE PREPARATION OF AGOMELATINE USING NOVEL INTERMEDIATES | SYMED LABS LIMITED (IN) | 2014-05-01 | — | — | WO | disclosed |
| EP-2580183-A2 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE AND NEW CRYSTALLINE FORM | GADOR S.A. (AR) | 2013-04-17 | — | — | EP | disclosed |
| WO-2011154140-A2 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE AND NEW CRYSTALLINE FORM | GADOR S.A. (AR) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011154140-A2 | NEW PROCESS FOR THE PREPARATION OF N-[2-(7-METHOXY-1-NAPHTHYL)-ETHYL]ACETAMIDE AND NEW CRYSTALLINE FORM | GADOR S.A. (AR) | 2011-12-15 | — | — | WO | disclosed |
| US-6235789-B1 | GLANDULAR DISORDERS; SLEEP DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| US-5661186-A | MELATONERGIC EFFECT; CENTRAL NERVOUS SYSTEM DISODERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0781271-A1 | BENZOCYCLOALKENE COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1997-07-02 | — | — | EP | disclosed |
| EP-0728738-A1 | Tetralinyl- and indanyl-ethylamides having melatonergic activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-28 | — | — | EP | disclosed |
| WO-1996008466-A1 | BENZOCYCLOALKENE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-03-21 | — | — | WO | disclosed |